Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    Advanced Search
    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Canadian Federal Government
        • Canadian Municipal Government
        • Canadian Provincial Government
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Advanced Search
    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • IR
    • All Products
    • Become a Client
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • General Enquiries
    • Media
    • Worldwide Offices
    • Hamburger menu
    • Cision Canada
    • Send a Release
    • FR
      • Phone

      • 877-269-7890 from 8 AM - 10 PM ET

      • ALL CONTACT INFO
      • Contact Cision

        877-269-7890
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • 3 News in Focus
      • 5 Business
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • IR
      • All Products
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • Become a Client
      • Request a Demo
      • Editorial Bureaus
      • Partnerships
      • General Enquiries
      • Media
      • Worldwide Offices
      • General Enquiries
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business) Business
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Canadian First: Man Living with HIV in 'Sustained Remission' After Bone Marrow Transplant

      University Health Network's logo. (CNW Group/University Health Network)

      News provided by

      University Health Network

      Apr 25, 2026, 18:00 ET

      Share this article

      Share this article


      Doctors at UHN's Toronto General Hospital and Princess Margaret Cancer Centre, together with St. Michael's Hospital (Unity Health Toronto), and the University of Toronto, report a case of possible HIV cure following a bone marrow (BM) transplant, in a man dubbed the Toronto patient.

      TORONTO, April 25, 2026 /CNW/ - In a Canadian first, clinicians and researchers at University Health Network (UHN), Unity Health Toronto, and the University of Toronto report a case of sustained HIV remission – and possible cure – following a bone marrow transplant for cancer.

      Continue Reading
      Dr. Sharon Walmsley, Director of the HIV Clinic at UHN's Toronto General Hospital and Speck Family Chair in Emerging Infectious Diseases. Courtesy: UHN. (CNW Group/University Health Network)
      Dr. Sharon Walmsley, Director of the HIV Clinic at UHN's Toronto General Hospital and Speck Family Chair in Emerging Infectious Diseases. Courtesy: UHN. (CNW Group/University Health Network)
      Dr. Mario Ostrowski, clinician-scientist at St. Michael’s Hospital (Unity Health Toronto) and Ontario HIV Treatment Network Applied Research Chair. Courtesy: JOHNNY GUATTO/UNIVERSITY OF TORONTO. (CNW Group/University Health Network)
      Dr. Mario Ostrowski, clinician-scientist at St. Michael’s Hospital (Unity Health Toronto) and Ontario HIV Treatment Network Applied Research Chair. Courtesy: JOHNNY GUATTO/UNIVERSITY OF TORONTO. (CNW Group/University Health Network)

      The case was led by Dr. Sharon Walmsley, Director of the HIV Clinic at UHN's Toronto General Hospital, and Dr. Mario Ostrowski, clinician-scientist at St. Michael's Hospital (Unity Health Toronto), working in collaboration with transplant and cancer specialists across UHN, Unity Health Toronto, and the University of Toronto.

      Presented today at the Canadian Association of HIV Research Conference, the report describes a Toronto individual living with HIV for 27 years who developed acute myelogenous leukemia and underwent a bone marrow transplant.

      The bone marrow transplant took place at the Hans Messner Allogeneic Transplant Program at UHN's Princess Margaret Cancer Centre and used donor stem cells with a rare genetic mutation that provides HIV resistance, following an international donor search to identify a suitable match.

      Researchers observed a progressive decline in HIV levels in the patient's cells following the transplant. The individual discontinued antiretroviral therapy (ART) in July 2025. As of April 2026, HIV remains undetectable using highly sensitive laboratory testing, and no HIV‑specific immune responses have been detected – a finding consistent with cases considered cured internationally.

      Some of the laboratory work supporting this case was carried out in the Toronto High Containment Facility, a specially equipped lab space that allows researchers to study pathogens like HIV in a safe and secure way. Based at U of T, the facility is a key research infrastructure asset for researchers across the city, driving advances in infectious disease prevention, detection and treatment.

      Significance

      To date, just 10 patients worldwide are considered cured of HIV following similar procedures. The Toronto patient would join the small group if he continues to have undetectable levels of HIV. He is currently considered to be in 'sustained remission.'

      "The small but growing number of these cases prove an HIV cure is possible," says Dr. Walmsley, who is also the Speck Family Chair in Emerging Infectious Diseases and professor at the University of Toronto's Temerty Faculty of Medicine. "Cases such as these provide important information for researchers to find ways to eradicate HIV from the body. It is not possible to offer bone marrow transplant for those without another indication, such as leukemia, given the risks of the procedure."

      "HIV infection, although well controlled with ART, still carries enormous stigma and discrimination," says Dr. Mario Ostrowski, who is also the Ontario HIV Treatment Network Applied Research Chair and professor at the University of Toronto's Temerty Faculty of Medicine. "One percent of people of European ethnicity have bone marrows that are resistant to HIV infection. A bone marrow transplant from these donors can provide a potential cure. Transplant provides clues to develop similar, less toxic and less expensive therapies by studying these individuals."

      "This case represents years of careful clinical work, close monitoring, and collaboration across specialties," says hematologist Dr. Tommy Alfaro Moya with UHN's Princess Margaret Cancer Centre, who was involved in the patient's post‑transplant care. "This case offers critical insight into how HIV can be eliminated from the body, informing safer approaches in the future."

      An estimated 65,270 people were living with HIV in Canada at the end of 2022, according to the Public Health Agency of Canada. The World Health Organization estimates there are more than 40 million people living with HIV globally.

      Case Background

      The Toronto patient was diagnosed with Stage 4 Burkitt's lymphoma and HIV infection in 1999. He achieved complete remission after chemotherapy and viral suppression with ART. HIV-infected persons need to take antiretroviral therapy (ART) for life, because HIV can form a reservoir in the body that can be awakened if ART is stopped.

      More than 20 years later, in July 2020, he developed myelodysplastic syndrome as a long-term consequence of chemotherapy. The condition progressed to acute myelogenous leukemia in November 2021.

      Bone marrow transplants using HIV-resistant stem cells are very expensive, and not standard treatment for HIV. They are only considered for patients who also require a transplant to treat a life-threatening blood cancer. The procedure carries significant risks and is highly complex.

      The Toronto patient wishes to remain anonymous.

      About University Health Network

      UHN is Canada's Hospital -- ranked #2 in the world, #1 in Canada. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre. As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. UHN has the largest hospital-based research program in Canada, with major research in neurosciences, cardiology, transplantation, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. UHN is a research hospital affiliated with the University of Toronto.

      About Unity Health Toronto

      Unity Health Toronto is a leading Canadian health research institution with a wingspan across Toronto's core. Unity Health Toronto's strength lies in the combined expertise of its three hospital sites: St. Joseph's Health Centre, a community academic and acute care hospital supporting Toronto's west end; St. Michael's Hospital, a research-intensive academic health sciences centre affiliated with the University of Toronto with world-class specialty programs for complex cases; and Providence Healthcare, a campus of care for seniors, rehabilitation and long-term care. Our satellite clinics offer team-based primary care and community-based services. We aim to provide compassionate, high-quality care at every stage of our patients' health journey, from pediatric to primary care, urgent and acute care, world-class specialty care programs, seniors care, rehabilitation, long-term care, palliative care and advanced care for the most complex patients.

      About the Toronto High Containment Facility at the University of Toronto

      The Toronto High Containment Facility (THCF) provides secure, state-of-the-art laboratory infrastructure for research involving infectious pathogens requiring enhanced biosafety controls. Operating under stringent regulatory and safety standards, the THCF enables critical research in infectious disease, immunology, diagnostics and medical countermeasure development. The facility is a cornerstone of the Emerging and Pandemic Infections Consortium (EPIC), a University of Toronto Institutional Strategic Initiative that brings together U of T, The Hospital for Sick Children, Sinai Health, Sunnybrook Health Sciences Centre, Unity Health Toronto and University Health Network to drive innovative approaches to infectious diseases and build rapid response capacity to health emergencies.

      SOURCE University Health Network

      Media Contacts: Leslie Whyte Zhou, Senior Communications Advisor, Media Relations, University Health Network, [email protected]; Ana Fernandes, Manager, External Communications, University Health Network, [email protected]; Unity Health Toronto, [email protected]

      Modal title

      Organization Profile

      University Health Network

        Also from this source

      • UHN releases national blueprint to turn Canadian discovery into economic strength

      • Early-stage study shows novel immunotherapy may benefit patients with treatment-resistant solid tumours

      • Media Advisory: Canada Leads at One Year - UHN Accelerating the Future of Health Innovation

      Contact PR Newswire

      • 866-245-2317
        from 7:30 AM - 6:30 PM ET
      • Become a Client
      • Request a Demo
      • Editorial Bureaus
      • Partnerships
      • General Enquiries
      • Media

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • Investor Relations

      About

      • About PR Newswire
      • About Cision
      • Careers
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • Platform Login
      • Privacy Policy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact Cision

      Products

      About

      My Services
      • All News Releases
      • Platform
      • Next Gen Communications Cloud
      • Cision Communications Cloud
      • my CNW
      877-269-7890
      from 8 AM - 10 PM ET
      • Terms of Use
      • Information Security Policy
      • Site Map
      • Cookie Settings
      • Accessibility Statement
      Copyright © 2026 CNW Group Ltd. All Rights Reserved. A Cision company.